• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.

作者信息

Ernst Thomas, Busch Melinda, Rinke Jenny, Ernst Jana, Haferlach Claudia, Beck James F, Hochhaus Andreas, Gruhn Bernd

机构信息

Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.

Sektion für Hämatologie, Onkologie und Stammzelltransplantation, Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Jena, Jena, Germany.

出版信息

Leukemia. 2018 Sep;32(9):2046-2049. doi: 10.1038/s41375-018-0157-2. Epub 2018 Jun 13.

DOI:10.1038/s41375-018-0157-2
PMID:29899367
Abstract
摘要

相似文献

1
Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.慢性髓性白血病儿童和青年中ASXL1突变频繁。
Leukemia. 2018 Sep;32(9):2046-2049. doi: 10.1038/s41375-018-0157-2. Epub 2018 Jun 13.
2
ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.伊朗慢性髓性白血病患者中ASXL1和JAK2V617F基因突变筛查
Asia Pac J Clin Oncol. 2017 Apr;13(2):e41-e47. doi: 10.1111/ajco.12588. Epub 2016 Sep 19.
3
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.基于纳米孔MinION技术的深度测序对BCR-ABL1阳性白血病进行突变分析。
Exp Mol Pathol. 2017 Aug;103(1):33-37. doi: 10.1016/j.yexmp.2017.06.007. Epub 2017 Jun 27.
4
Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.双色-双融合易位荧光原位杂交技术检测bcr/abl融合基因的临床意义
Zhonghua Zhong Liu Za Zhi. 2002 Jul;24(4):364-6.
5
New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.在接受酪氨酸激酶抑制剂治疗的慢性髓性白血病患者中，通过变性高效液相色谱法筛选6号外显子bcr-abl突变时检测到的新突变。
Leuk Lymphoma. 2009 Jul;50(7):1148-54. doi: 10.1080/10428190902930496.
6
Mutations in ABL kinase domain are associated with inferior progression-free survival.ABL 激酶结构域的突变与较差的无进展生存期相关。
Leuk Lymphoma. 2010 Jun;51(6):1072-8. doi: 10.3109/10428191003729741.
7
Molecular monitoring of response to imatinib (Glivec) in chronic myeloid leukemia patients: experience at a tertiary care hospital in Saudi Arabia.慢性髓性白血病患者对伊马替尼（格列卫）反应的分子监测：沙特阿拉伯一家三级医疗医院的经验。
Genet Test Mol Biomarkers. 2010 Feb;14(1):67-74. doi: 10.1089/gtmb.2009.0126.
8
ETV6/ABL fusion is rare in Ph-negative chronic myeloid disorders.ETV6/ABL融合在Ph阴性慢性髓系疾病中罕见。
Leukemia. 1998 Jul;12(7):1167-8. doi: 10.1038/sj.leu.2401091.
9
[Dual-color/dual-fusion interphase fluorescence in situ hybridization probe for monitoring tumor load during imatinib therapy for chronic myeloid leukemia].[用于监测慢性髓性白血病伊马替尼治疗期间肿瘤负荷的双色/双融合间期荧光原位杂交探针]
Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan;30(1):123-5.
10
Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia.马来西亚伊马替尼耐药慢性髓性白血病患者中BCR-ABL T315I突变的患病率
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3317-3320. doi: 10.31557/APJCP.2018.19.12.3317.

引用本文的文献

1
The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers.慢性髓系白血病的生物学：新见解与生物标志物概述
Front Oncol. 2025 May 8;15:1546813. doi: 10.3389/fonc.2025.1546813. eCollection 2025.
2
Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia.与儿童、成人以及BCR::ABL1阳性急性淋巴细胞白血病相比，慢性髓性白血病青少年和年轻成人的体细胞突变与预后
Leukemia. 2025 Apr 28. doi: 10.1038/s41375-025-02609-3.
3
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis.
骨髓纤维化患者静脉和动脉血栓形成事件的分子预测指标
Ann Hematol. 2025 Apr 27. doi: 10.1007/s00277-025-06361-7.
4
Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.酪氨酸激酶抑制剂时代儿童慢性髓性白血病初发晚期阶段的良好预后。
Int J Hematol. 2025 Mar 15. doi: 10.1007/s12185-025-03953-x.
5
A high proportion of germline variants in pediatric chronic myeloid leukemia.儿童慢性髓性白血病中存在大量种系变异。
Mol Cancer. 2024 Sep 26;23(1):206. doi: 10.1186/s12943-024-02109-5.
6
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia.欧洲白血病网络实验室关于慢性髓性白血病诊断和管理的建议。
Leukemia. 2023 Nov;37(11):2150-2167. doi: 10.1038/s41375-023-02048-y. Epub 2023 Oct 4.
7
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia.儿童慢性期慢性髓性白血病的体细胞变异分析
Haematologica. 2024 Mar 1;109(3):942-947. doi: 10.3324/haematol.2023.283800.
8
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights.慢性髓性白血病的预后：基线因素、动态风险评估和新的见解。
Cells. 2023 Jun 23;12(13):1703. doi: 10.3390/cells12131703.
9
A customized mass array panel for :: tyrosine kinase domain mutation screening in chronic myeloid leukemia.一种用于慢性髓性白血病酪氨酸激酶结构域突变筛查的定制化质谱分析芯片。
J Mass Spectrom Adv Clin Lab. 2023 Apr 13;28:122-132. doi: 10.1016/j.jmsacl.2023.04.002. eCollection 2023 Apr.
10
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.台湾多中心经验：一线伊马替尼治疗的慢性髓性白血病儿童的分子反应较慢，但与成人相比生存相当。
Br J Cancer. 2023 Mar;128(7):1294-1300. doi: 10.1038/s41416-023-02162-9. Epub 2023 Jan 30.